Granulomatous amoebic encephalitis caused by Acanthamoeba amoebae of genotype T2 in a human immunodeficiency virus-negative patient.
Acanthamoeba amoebae of genotype T2 were identified as the causative agent of Acanthamoeba skin lesions and granulomatous amoebic encephalitis (GAE) in a human immunodeficiency virus-negative patient with underlying tuberculosis. To our knowledge this, is the first case of GAE involving genotype T2.
Walochnik
Julia
J
Department of Medical Parasitology, Clinical Institute of Hygiene and Medical Microbiology, Medical University of Vienna, Kinderspitalgasse 15, 1095 Vienna, Austria. julia.walochnik@meduniwien.ac.at
Aichelburg
Alexander
A
Assadian
Ojan
O
Steuer
Andrea
A
Visvesvara
Govinda
G
Vetter
Norbert
N
Aspöck
Horst
H
D000048:Acanthamoeba / Q000145:classification / Q000235:genetics / Q000302:isolation & purification*; D000328:Adult; D000562:Amebiasis / Q000188:drug therapy / Q000469:parasitology / Q000473:pathology*; D000583:Amikacin / Q000627:therapeutic use; D000818:Animals; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D000995:Antitubercular Agents / Q000627:therapeutic use; D016054:DNA, Protozoan / Q000737:chemistry / Q000235:genetics; D004660:Encephalitis / Q000188:drug therapy / Q000469:parasitology* / Q000473:pathology; D005838:Genotype; D015658:HIV Infections / Q000150:complications; D006801:Humans; D008297:Male; D008969:Molecular Sequence Data; D010767:Phosphorylcholine / Q000031:analogs & derivatives / Q000627:therapeutic use; D017422:Sequence Analysis, DNA; D012876:Skin Diseases, Parasitic / Q000469:parasitology / Q000473:pathology; D014376:Tuberculosis / Q000150:complications
D000981:Antiprotozoal Agents; D000995:Antitubercular Agents; D016054:DNA, Protozoan; D010767:Phosphorylcholine; C039128:miltefosine; D000583:Amikacin